remdesivir

Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Eli Lilly
FDA
COVID-19
Emergency Use Authorization
olumiant
remdesivir
Flag link:
WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients
WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients
Stat
WHO
Gilead Sciences
remdesivir
COVID-19
Veklury
Flag link:
After WHO trial failure, influential medical group advises against Gilead's remdesivir in COVID critical care: Reuters
After WHO trial failure, influential medical group advises against Gilead's remdesivir in COVID critical care: Reuters
Fierce Pharma
Gilead Sciences
remdesivir
Veklury
COVID-19
Flag link:
Will Gilead's Remdesivir Only Be a Short-Lived Success Story?
Will Gilead's Remdesivir Only Be a Short-Lived Success Story?
Motley Fool
Gilead Sciences
remdesivir
COVID-19
Veklury
Flag link:
Gilead should give up FDA voucher for remdesivir, patient advocates say
Gilead should give up FDA voucher for remdesivir, patient advocates say
Beckers Hospital Review
Gilead Sciences
remdesivir
FDA
Public Citizen
Flag link:
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
Gilead Sciences
earnings
Veklury
remdesivir
COVID-19
Flag link:
WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
Reuters
Gilead Sciences
remdesivir
WHO
clinical trials
COVID-19
Flag link:
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Motley Fool
Gilead Sciences
remdesivir
FDA
COVID-19
Flag link:
Smaller biotech firms continue to bring new approaches against COVID-19 complications
Smaller biotech firms continue to bring new approaches against COVID-19 complications
Biotechblog
COVID-19
remdesivir
hydroxychloroquine
Lopinavir
interferon
WHO
FSD Pharma
Q Biomed
Aqualung Pharmaceuticals
Flag link:
Massive Covid-19 Drug Trial Underscores Importance Of Controlled Clinical Studies
Massive Covid-19 Drug Trial Underscores Importance Of Controlled Clinical Studies
Forbes
WHO
clinical trials
COVID-19
remdesivir
Gilead Sciences
interferon
Flag link:
WHO: Remdesivir Does Not Substantially Affect COVID-19 Patient Mortality
WHO: Remdesivir Does Not Substantially Affect COVID-19 Patient Mortality
Motley Fool
Gilead Sciences
remdesivir
Veklury
COVID-19
clinical trials
Flag link:
EU makes 1 billion-euro bet on Gilead's COVID drug before trial results
EU makes 1 billion-euro bet on Gilead's COVID drug before trial results
Reuters
Europe
Gilead Sciences
COVID-19
remdesivir
Flag link:
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Yahoo/Reuters
Gilead Sciences
remdesivir
FDA
COVID-19
Flag link:
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
Flag link:
European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir
European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir
Beckers Hospital Review
EMA
Europe
Gilead Sciences
remdesivir
COVID-19
Flag link:
President Trump Begins Treatment With Remdesivir from Gilead Sciences
President Trump Begins Treatment With Remdesivir from Gilead Sciences
Motley Fool
Donald Trump
COVID-19
Gilead Sciences
remdesivir
Veklury
Flag link:
Gilead to distribute COVID-19 drug Veklury in US, taking over from federal government
Gilead to distribute COVID-19 drug Veklury in US, taking over from federal government
BioPharma Dive
Gilead Sciences
remdesivir
Veklury
COVID-19
Flag link:
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Stat
Gilead Sciences
remdesivir
COVID-19
profits
drug pricing
Flag link:
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Eli Lilly
olumiant
Gilead Sciences
remdesivir
Veklury
drug pricing
COVID-19
Flag link:
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Eli Lilly
Incyte
olumiant
COVID-19
remdesivir
Gilead Sciences
Flag link:

Pages